MediPharm Labs Corp. (TSX: LABS) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based ...
Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected revenue range to $1.6 – $2.0 billion Improves 2025 expected GAAP operating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback